CYTARABINE
Generic: CYTARABINE
Meitheal Pharmaceuticals Inc.Manufacturer
INTRATHECAL, INTRAVENOUS, SUBCUTANEOUSRoute
CYTARABINEActive Substance
2018-07-17Original Approval
CYTARABINE is FDA application ANDA205696, sponsored by MEITHEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FEBRILE NEUTROPENIA
7,662 reports
2
OFF LABEL USE
5,107 reports
3
PYREXIA
4,203 reports
4
NEUTROPENIA
3,686 reports
5
DRUG INEFFECTIVE
3,161 reports
6
THROMBOCYTOPENIA
2,966 reports
7
SEPSIS
2,954 reports
8
DISEASE PROGRESSION
2,773 reports
9
PNEUMONIA
2,357 reports
10
MYELOSUPPRESSION
2,263 reports